555 Bionanotechnology for Gene and Drug Delivery II


Description:
Bionanotechnology uses concepts from chemistry, physics, and molecular biology to identify components and processes for the construction of nanomaterials and nanodevices for health care. This session invites papers that focus on the design and development of nanomaterials and nanodevices for gene and drug delivery. Topics of interest include, but are not limited to: novel methods and compositions to design gene and drug delivery systems at the nanoscale level, and the effects of the sizes of gene and drug delivery systems on gene and drug release kinetics, and pharmacokinetics, cellular uptake, biological transport, and bioefficacy of gene- and drug-carrier complexes. Bionanotechnology Graduate students: By applying to this session you may be eligible for the 22b Bionanotechnology Graduate Student Award Session (22B09) established to honor students whose research achievements in bionanotechnology demonstrates a high level of excellence. See session 22B09 for more details.

Sponsor:
Bionanotechnology
Co-Sponsor(s):
Biomaterials (08B)


Chair:
Elizabeth Nance
Professor
University of Washington
Chemical Engineering
Seattle, WA
Phone Number: 206-543-2216
Email: eanance@uw.edu

Co-Chair:
Joo-Youp Lee
Associate Professor
University of Cincinnati
Chemical Engineering program, Department of Biomedical, Chemical, and Environmental Engineering
Cincinnati, OH
45221
Email: leejo@ucmail.uc.edu


Papers:
555a
Optimization of Liposome-Hollow Gold Nanoparticle for mRNA Delivery
Anisha Veeren, University of Minnesota; Mark Osborn, University of Minnesota; Sarah Merkel, University of Minnesota; JeongEun Shin, University of Minnesota; Joesph A. Zasadzinski, University of Minnesota
555b
Lipid Nanoparticle Ionization at Endosomal pH Is a Cell-Free Predictor of mRNA Delivery Efficacy In Vivo
Khalid A. Hajj, Carnegie Mellon University; Rebecca Ball, Carnegie Mellon University; Sarah Deluty, Carnegie Mellon University; Shridhar Singh, Carnegie Mellon University; Christopher Knapp, Carnegie Mellon University; Kathryn A. Whitehead, Carnegie Mellon University
555c
pH Responsive Polycationic Nanoparticles for siRNA Delivery in Inflammatory Bowel Diseases
Aaliyah B. Shodeinde, The University of Texas at Austin; Angela Wagner, The University of Texas at Austin; Nicholas A. Peppas, University of Texas at Austin
555d
Lipid Nanoparticle Mediated Drug Delivery for Targeting Inflammation Site in Atherosclerosis
Rashi Porwal, University of Nebraska-Lincoln; Stephen L. Hayward, University of Nebraska-Lincoln; Xiang-der Liu, University of Nebraska Medical Center; Yiannis Chatzizisis, University of Nebraska Medical Center; Srivatsan Kidambi, University of Nebraska-Lincoln
555e
Internalization and Endocytic Trafficking of 3WJ RNA Nanoparticles for siRNA Delivery
Landon A. Mott, University of Kentucky; Peixuan Guo, Ohio State University; Daniel W. Pack, University of Kentucky
555f
Synthesis of Poly(Aspartic Acid)-Doxorubicin Prodrug for Sequential Delivery of Afatinib and Doxorubicin
Mina Jafari, University of Cincinnati; Vishnu Sriram, University of Cincinnati; Joo-Youp Lee, University of Cincinnati
555g
Co-Delivery of 2-DG and V9302 Via a Prodrug Micellar Formulation for Synergistic Targeting of Metabolism in Cancers
Zhangyi Luo, University of Pittsburgh; Yang Wu-yue Liu, University of Pittsburgh; Yan He, University of Pittsburgh; Jingjing Sun, University of Pittsburgh; Song Li, University of Pittsburgh
555h
Engineering PEO-Pdlla Nanoparticles Containing the PI3K Inhibitor LY294002
Austin Fergusson, Virginia Tech; Ami Jo, Macromolecules Innovation Institute; Richey M. Davis, Virginia Tech
555i
Targeting Tumor Associated Macrophages with PAMAM Dendrimers Improves Therapeutic Efficacy in Glioblastoma
Kevin Liaw, Johns Hopkins University School of Medicine; Rishi Sharma, Center for Nanomedicine; Rajsekhar Reddy, Center for Nanomedicine; Sujatha Kannan, Johns Hopkins University School of Medicine; Rangaramanujam Kannan, Johns Hopkins University
555j
Programming Tumor-Clearing Macrophages with Targeted Gene Therapy
Fan Zhang, Fred Hutchinson Cancer Research Institute; Michael Coon, Fred Hutchinson Cancer Research Institute; Sirkka Stephan, Fred Hutchinson Cancer Research Institute; Smitha Pillai, Fred Hutchinson Cancer Research Institute; Matthias Stephan, University of Washington
Abstract Submissions Closed
See more of this Group/Topical: Nanoscale Science and Engineering Forum
<< Previous Session | Next Session >>